Idiopathic Parkinson Disease
Neurology
1
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
UP
UCB PharmaBelgium - Brussels
2 programs1
LevetiracetamPhase 21 trial
Transdermal Rotigotine User Surveillance StudyN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
UCB PharmaLevetiracetam
UCB PharmaTransdermal Rotigotine User Surveillance Study
Clinical Trials (2)
Total enrollment: 2,225 patients across 2 trials
Levetiracetam Treatment in Adult Subjects With Parkinson's Disease Experiencing Troublesome Dyskinesias
Start: Jul 2003Est. completion: Nov 200430 patients
Phase 2Completed
Transdermal Rotigotine User Surveillance Study
Start: Jun 2006Est. completion: Apr 20142,195 patients
N/ACompleted
Related Jobs in Neurology
Director, Distribution & Services
Xenon Pharmaceuticals
Remote
8h ago
Senior Medical Science Liaison (NYC Tri-State)
Xenon Pharmaceuticals
Remote
8h ago
$208K - $234K/yr
Director of Medical Affairs
CoMind
Miami, FL
9h ago
Director of Finance
CoMind
London, UK
9h ago
Electronics Engineering Manager
CoMind
London, UK
9h ago
Director of Information Technology
Zavation Medical Products
9h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space